retatrutide dose in trials A Clinician's Guide to Dosing retatrutide type 2 diabetes trial

19 December 2024: FDA confirms tirzepatide shortage is still over, gives compounders a grace period Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s

Regulatory Status Disclosure: The FDA declared the semaglutide drug shortage resolved in February 2025 and the tirzepatide drug shortage resolved in October 2024

Why We Picked Them: Physician team leads the clinical team

Abstracts Pine MB, Bing OHL, Brooks WW, Lustig RH, Abelmann WH: Changes in ion flux in ischemic rat myocardium

This means food stays in your stomach longer than usual, which can cause symptoms ranging from bloating to malnutrition

(PubMed) Drain PK, Kupka R, Mugusi F, Fawzi WW